Peters interest is in pharmacogenetics and personalized medicine. Ongoing projects aim to delineate the genetic basis of adverse drug events such as drug induced long QT syndrome and Torsades des pointes using next-generation sequencing methods.
Board-certified cardiologist with a passion for fostering team growth, collaboration, continuous learning and drive advancements in health care. I also have a strong interest in drug development, disease mechanisms, and personalized medicine.
Skilled in research with over 130 publications in peer-reviewed journals